Lifestyle and Socioeconomic Transition and Health Consequences of Breast Cancer in the East Asia Region, From 1990 to 2019

Background Due to its higher prevalence and heterogeneity, female breast cancer (BC) is the widest disease throughout the world. We sought to assess the epidemiological and sociodemographic transitions of BC and to identify the potential risk factors attributed to burden of BC in East Asia. Methods At the regional level of East Asia and at a national level of East Asian countries, we investigated the burden of the incidence of female BC, mortality, and disability-adjusted life years (DALYs) in 2019 and assessed the epidemiological, socioeconomic, and health-linked disparities in incidence of BC and mortality over a 30-year period. The changes in BC’s mortality and DALYs between 1990 and 2019, attributable to varying risk factors, were evaluated in different age groups. Results In 2019, the incidence of and mortality from and DALYs of BC were estimated to be 382,321 (95% UI: 303,308–477,173) incidence cases [age-standardized rate (ASR) of 35.69 per 100,000; 28.32–44.54], 98,162 (79,216–120,112) deaths (ASR of 9.12; 7.36–11.13), and 3,024,987 (2,477, 984–3,659,370) DALYs with an ASR of 282.15 (230.81–341.19) in 2019. It was also observed that out of four most representative locations of East Asia, two (China and Japan) showed more than 60% increase in age-standardized incidence rate between 1990 and 2019. While only Japan females showed a significant rise of 15.3% (95% UI: 2.3–28) in ASR of death and 12.6% (95% UI: 0.5–26.9) in ASR of DALYs between 1990 and 2019. Inclusively, 88 and 81% variations were explained in the incidence of BC and death due to change in sociodemographic index (SDI) in 2019, in East Asia. The highest positive percent changes in death and DALYs between 1990 and 2019 were attributable to high body mass index (BMI), high fasting plasma glucose (FPG), and alcohol consumption in East Asia. Conclusion The burden of death and disability from female BC is the result of multiple risk factors, mainly due to behavioral and metabolic risk factors. The increase of the incidence is related to the westernized lifestyle and diet habits and the improvement of screening and diagnosis techniques in the recent years, whereas the increase in DALYs is mainly attributed to high BMI, high FPG, alcohol use, and high diet in red meat.

[1]  Rajesh Sharma,et al.  Breast Cancer Mortality Trends and Predictions to 2030 and Its Attributable Risk Factors in East and South Asian Countries , 2022, Frontiers in Nutrition.

[2]  Chuanhua Yu,et al.  Epidemiological and sociodemographic transitions of female breast cancer incidence, death, case fatality and DALYs in 21 world regions and globally, from 1990 to 2017: An Age-Period-Cohort Analysis , 2021, Journal of advanced research.

[3]  S. Tyrovolas,et al.  Organized breast cancer screening not only reduces mortality from breast cancer but also significantly decreases disability-adjusted life years: analysis of the Global Burden of Disease Study and screening programme availability in 130 countries , 2021, ESMO open.

[4]  Yafeng Wang,et al.  Trends and Projections in Breast Cancer Mortality among four Asian countries (1990–2017): Evidence from five Stochastic Mortality Models , 2020, Scientific Reports.

[5]  Yafeng Wang,et al.  A Hierarchical Age–Period–Cohort Analysis of Breast Cancer Mortality and Disability Adjusted Life Years (1990–2015) Attributable to Modified Risk Factors among Chinese Women , 2020, International journal of environmental research and public health.

[6]  Z. Dai,et al.  Global burden of breast cancer and attributable risk factors in 195 countries and territories, from 1990 to 2017: results from the Global Burden of Disease Study 2017 , 2019, Journal of Hematology & Oncology.

[7]  W. Han,et al.  Contrasting Epidemiology and Clinicopathology of Female Breast Cancer in Asians versus the US Population. , 2019, Journal of the National Cancer Institute.

[8]  H. Salehiniya,et al.  Epidemiological characteristics of and risk factors for breast cancer in the world , 2019, Breast cancer.

[9]  Dan J Stein,et al.  Global, regional, and national burden of Alzheimer's disease and other dementias, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 , 2019, The Lancet Neurology.

[10]  H. Arem,et al.  Adherence to lifestyle-related cancer prevention guidelines and breast cancer incidence and mortality. , 2018, Annals of epidemiology.

[11]  S. Nie,et al.  Trends in incidence and mortality of female breast cancer during transition in Central China , 2018, Cancer management and research.

[12]  Haniye Sadat Sajadi,et al.  Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 , 2018, The Lancet.

[13]  Haniye Sadat Sajadi,et al.  Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 , 2018, The Lancet.

[14]  Mohammad Hossein Khosravi,et al.  Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017 , 2018, Lancet.

[15]  M. Gail,et al.  Proportion of U.S. Trends in Breast Cancer Incidence Attributable to Long-term Changes in Risk Factor Distributions , 2018, Cancer Epidemiology, Biomarkers & Prevention.

[16]  Mohammad Hossein Khosravi,et al.  Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2016 , 2018, JAMA oncology.

[17]  Takao Suzuki.  Health status of older adults living in the community in Japan: Recent changes and significance in the super‐aged society , 2018, Geriatrics & gerontology international.

[18]  J. Sitt,et al.  Understanding breast cancer screening--past, present, and future. , 2018, Hong Kong medical journal = Xianggang yi xue za zhi.

[19]  M. Delgado-Rodríguez,et al.  Systematic review and meta-analysis. , 2017, Medicina intensiva.

[20]  Eyal Oren,et al.  Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 , 2017, Lancet.

[21]  M. Curado,et al.  Breast cancer screening in developing countries , 2017, Clinics.

[22]  Richard Sullivan,et al.  The global burden of women’s cancers: a grand challenge in global health , 2017, The Lancet.

[23]  R. Kaaks,et al.  Obesity and breast cancer , 2019, Oncolog-Hematolog.ro.

[24]  Patrick C. Brennan,et al.  Descriptive epidemiology of breast cancer in China: incidence, mortality, survival and prevalence , 2016, Breast Cancer Research and Treatment.

[25]  M. Nojima,et al.  Weight Gain and Alcohol Drinking Associations with Breast Cancer Risk in Japanese Postmenopausal Women - Results from the Japan Collaborative Cohort (JACC) Study. , 2016, Asian Pacific journal of cancer prevention : APJCP.

[26]  L. Carey,et al.  Breast Cancer Screening in Low- and Middle-Income Countries: A Perspective From Malawi , 2015, Journal of global oncology.

[27]  Wei Wei,et al.  Red and processed meat intake and risk of breast cancer: a meta-analysis of prospective studies , 2015, Breast Cancer Research and Treatment.

[28]  K. Rhiem,et al.  Risikofaktoren und Prävention des Mammakarzinoms , 2015, Der Onkologe.

[29]  S. Dey,et al.  Preventing breast cancer in LMICs via screening and/or early detection: The real and the surreal. , 2014, World journal of clinical oncology.

[30]  A. M. Salinas-Martínez,et al.  Prediabetes, diabetes, and risk of breast cancer: a case-control study. , 2014, Archives of medical research.

[31]  C. G. Jung,et al.  THE REAL AND THE SURREAL , 2014 .

[32]  K. Jung-Choi,et al.  Hidden female smokers in Asia: a comparison of self-reported with cotinine-verified smoking prevalence rates in representative national data from an Asian population , 2011, Tobacco Control.

[33]  M. Lux,et al.  Diabetes and prognosis in a breast cancer cohort , 2011, Journal of Cancer Research and Clinical Oncology.

[34]  M. Coory,et al.  Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis , 2010, Breast Cancer Research and Treatment.

[35]  D. Chisholm,et al.  Effectiveness and cost-effectiveness of policies and programmes to reduce the harm caused by alcohol , 2009, The Lancet.

[36]  R. Gelber,et al.  The effect of body mass index (BMI) on disease-free and overall survival in node-positive breast cancer treated with docetaxel and doxorubicin-containing adjuvant chemotherapy: the experience of the BIG 02-98 trial , 2008 .

[37]  F. Schmidt.  Meta-Analysis , 2008 .

[38]  V. McCormack,et al.  Breast Density and Parenchymal Patterns as Markers of Breast Cancer Risk: A Meta-analysis , 2006, Cancer Epidemiology Biomarkers & Prevention.

[39]  F. Clavel-Chapelon,et al.  Anthropometric measures, endogenous sex steroids and breast cancer risk in postmenopausal women: A study within the EPIC cohort , 2006, International journal of cancer.

[40]  T. Holford.  Age–Period–Cohort Analysis , 2005 .

[41]  P. Hall,et al.  Profound changes in breast cancer incidence may reflect changes into a Westernized lifestyle: A comparative population‐based study in Singapore and Sweden , 2005, International journal of cancer.

[42]  F. Bray,et al.  The changing global patterns of female breast cancer incidence and mortality , 2004, Breast Cancer Research.

[43]  M. Burns,et al.  Case-Control Study , 2020, Definitions.

[44]  C. Murray,et al.  On the comparable quantification of health risks: lessons from the Global Burden of Disease Study. , 1999, Epidemiology.

[45]  R. Mason,et al.  The metabolism of 17 beta-estradiol by lactoperoxidase: a possible source of oxidative stress in breast cancer. , 1994, Carcinogenesis.

[46]  Xiaodong Tan,et al.  Physical Activity and Risk of Breast Cancer: A Meta-Analysis of 38 Cohort Studies in 45 Study Reports. , 2019, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[47]  Marie Schmidt,et al.  HEAL TH AT A GLANCE , 2007 .

[48]  K. Nam,et al.  Meat products and consumption culture in the East. , 2010, Meat science.

[49]  K. Yoo.  Cancer prevention in the Asia Pacific region. , 2010, Asian Pacific journal of cancer prevention : APJCP.

[50]  R. Gelber,et al.  The effect of body mass index on overall and disease-free survival in node-positive breast cancer patients treated with docetaxel and doxorubicin-containing adjuvant chemotherapy: the experience of the BIG 02-98 trial , 2009, Breast Cancer Research and Treatment.